About Deborah Moorad
Form D filings for CorriXR Therapeutics in 2024 list Deborah Moorad as chief executive officer and director.
Deborah Moorad first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Deborah Moorad in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Deborah Moorad works with at each company, as listed on that company's latest Form D.
CorriXR Therapeutics, Inc. · Form D/A, Jan 29, 2024
JC
Jeffrey Carper
Director
JB
Jon Brilliant
Executive officer
JN
Janice Nevin
Director
SV
Stella Vnook
Director
EK
Eric Kmiec
Executive officer and director